Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Company

Daisy Thompson-Lake

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 11, 2026 · INTERVENTIONAL STUDY

Auricular Vagal Neuromodulation for Depression and Anxiety in Substance Use Disorder

ClinicalTrials.gov

This is a pilot feasibility and tolerability study not yet recruiting, with no posted results; it measures device acceptability and adherence, not clinical efficacy.

PreliminaryDaisy Thompson-Lake Substance Use Disorder (SUD)Transcutaneous Auricular Vagus Nerve Stimulation

Reported

Planned enrollment50

Study duration30 days

Daily device use targetapproximately 60 minutes

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support